Association of alpha B-crystallin genotypes with oral cancer susceptibility, survival, and recurrence in Taiwan

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Bau, Da Tian ^a   Tsai, Chia Wen ^a   Lin, Cheng Chieh ^a   Tsai, Ru Yin ^a   Tsai, Ming Hsui ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; BETA CRYSTALLIN;

AGED; ALLELE; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CRYAB GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PATHOGENESIS; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL TIME; TAIWAN; GENETIC PREDISPOSITION; GENETICS; MOUTH TUMOR; POLYMERASE CHAIN REACTION;

AGED; ALPHA-CRYSTALLIN B CHAIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MOUTH NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN;

EID: 80052516763     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016374     Document Type: Article

References (24)

1. Caplan DJ, Hertz-Picciotto I, (1998) Racial differences in survival of oral and pharyngeal cancer patients in North Carolina. J Public Health Dent 58: 36-43.
2. Moore RJ, Doherty DA, Do KA, Chamberlain RM, Khuri FR, (2001) Racial disparity in survival of patients with squamous cell carcinoma of the oral cavity and pharynx. Ethn Health 6: 165-177.
3. Shiboski CH, Shiboski SC, Silverman S Jr, (2000) Trends in oral cancer rates in the United States, 1973-1996. Community Dent Oral Epidemiol 28: 249-256.
4. Swango PA, (1996) Cancers of the oral cavity and pharynx in the United States: an epidemiologic overview. J Public Health Dent 56: 309-318.
5. Department of Health Taiwan (2008) Cancer registration system annual report. Taiwan, Department of Health.
6. Bhat SP, Nagineni CN, (1989) alpha B subunit of lens-specific protein alpha-crystallin is present in other ocular and non-ocular tissues. Biochem Biophys Res Commun 158: 319-325.
7. Iwaki T, Kume-Iwaki A, Goldman JE, (1990) Cellular distribution of alpha B-crystallin in non-lenticular tissues. J Histochem Cytochem 38: 31-39.
8. Sax CM, Piatigorsky J, (1994) Expression of the alpha-crystallin/small heat-shock protein/molecular chaperone genes in the lens and other tissues. Adv Enzymol Relat Areas Mol Biol 69: 155-201.
9. Chin D, Boyle GM, Williams RM, Ferguson K, Pandeya N, et al. (2005) Alpha B-crystallin, a new independent marker for poor prognosis in head and neck cancer. Laryngoscope 115: 1239-1242.
10. Lo WY, Tsai MH, Tsai Y, Hua CH, Tsai FJ, et al. (2007) Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin Chim Acta 376: 101-107.
11. Chang NW, Pei RJ, Tseng HC, Yeh KT, Chan HC, et al. (2010) Co-treating with arecoline and 4-nitroquinoline 1-oxide to establish a mouse model mimicking oral tumorigenesis. Chem Biol Interact 183: 231-237.
12. Boslooper K, King-Yin Lam A, Gao J, Weinstein S, Johnson N, (2008) The clinicopathological roles of alpha-B-crystallin and p53 expression in patients with head and neck squamous cell carcinoma. Pathology 40: 500-504.
13. Solares CA, Boyle GM, Brown I, Parsons PG, Panizza B, (2010) Reduced alphaB-crystallin staining in perineural invasion of head and neck cutaneous squamous cell carcinoma. Otolaryngol Head Neck Surg 142: S15-19.
14. Moyano JV, Evans JR, Chen F, Lu M, Werner ME, et al. (2006) AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J Clin Invest 116: 261-270.
15. Stronach EA, Sellar GC, Blenkiron C, Rabiasz GJ, Taylor KJ, et al. (2003) Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression. Cancer Res 63: 8648-8655.
16. Khuri FR, Kim ES, Lee JJ, Winn RJ, Benner SE, et al. (2001) The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev 10: 823-829.
17. Khuri FR, Lee JJ, Lippman SM, Kim ES, Cooper JS, et al. (2006) Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst 98: 441-450.
18. Bau DT, Tsai MH, Lo YL, Hsu CM, Tsai Y, et al. (2007) Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients. Anticancer Res 27: 1559-1564.
19. Bau DT, Tseng HC, Wang CH, Chiu CF, Hua CH, et al. (2008) Oral cancer and genetic polymorphism of DNA double strand break gene Ku70 in Taiwan. Oral Oncol 44: 1047-1051.
20. Chiu CF, Tsai MH, Tseng HC, Wang CL, Tsai FJ, et al. (2008) A novel single nucleotide polymorphism in ERCC6 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol 44: 582-586.
21. Chiu CF, Tsai MH, Tseng HC, Wang CL, Wang CH, et al. (2008) A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol 44: 898-902.
22. Hsu CF, Tseng HC, Chiu CF, Liang SY, Tsai CW, et al. (2009) Association between DNA double strand break gene Ku80 polymorphisms and oral cancer susceptibility. Oral Oncol 45: 789-793.
23. Tsai MH, Tseng HC, Liu CS, Chang CL, Tsai CW, et al. (2009) Interaction of Exo1 genotypes and smoking habit in oral cancer in Taiwan. Oral Oncol 45: e90-94.
24. Tseng HC, Tsai MH, Chiu CF, Wang CH, Chang NW, et al. (2008) Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan. Anticancer Res 28: 1687-1691.